News
Stay up-to-date on current women’s health news, articles and videos from Speaking of Women's Health, as well as developments from other women’s health news outlets.
Managing Urogenital and Vulvovaginal Atrophy in Breast Cancer Survivors Receiving Endocrine Therapy
A comprehensive approach to genitourinary syndrome of menopause.…
New medical procedure could delay menopause by 20 years
Operation could benefit thousands of women who experience serious health issues…
Testosterone May Rejuvenate Older Women's Sex Drive
(HealthDay News) -- Many older men take testosterone to boost their sex drive, but new research suggests that postmenopausal women who struggle with a sagging libido might want to follow suit.…
Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy
Patients with breast cancer receiving antiestrogen therapy, specifically aromatase inhibitors, often suffer from vaginal dryness, itching, irritation, dyspareunia, and dysuria, collectively known as…
Patients Will Soon Have an Additional Option When New Osteoporosis Treatment Hits Market
Romosozumab significantly reduced fracture risk, though close follow-up is required.…
For the First Time in North America, a Woman Gives Birth After Uterus Transplant From a Deceased Donor
A baby girl born last month at Cleveland Clinic has made history. She was the first baby in North America delivered by a mother who received a uterus transplant from a deceased donor.…
FDA OKs Wearable Device for Migraine Pain
The FDA has cleared a noninvasive device to relieve acute migraine pain. Nerivio Migra is a "first-in-category product," according to Theranica, the company that makes it. It is worn on the upper…
FDA approves new drug for women with low sexual desire disorder
The US Food and Drug Administration approved a drug to return sexual desire to some women with low libido.…
FDA Approves Oral Contraceptive Slynd
The US Food and Drug Administration (FDA) has approved Slynd (drospirenone) for use as an oral contraceptive pill. The pill contains drospirenone 4 mg and comes in sets of 24 active pills along with…
BioSyent Announces Health Canada Approval of New Women’s Health Product
BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that Health Canada has approved Tibella® (tibolone), indicated for the short-term treatment of vasomotor symptoms due to estrogen…
FDA Recalls Transvaginal Mesh for Treatment of Pelvic Organ Prolapse
Recall does not necessarily mean transvaginal mesh is defective.…